OGS has begun its funding season as the organization looks ahead to wrapping up 2023 and kicking off 2024.
Lois Schoenbrun
Advertisement
Articles by Lois Schoenbrun
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
BLA accepted, priority review granted by US FDA for Viridian Viridian Therapeutics’ veligrotug
2
Managing glaucoma in an ophthalmic practice: An artful approach
3
FDA CRL for SYD-101 sparks AAOMC statement on significance of myopia control
4
Crafting your own eyewear brand: An introduction to Sho Eyeworks and brand profitability
5